Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine. (Q43583250)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313808%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313808%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313808%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Toda M

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313808%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Martuza RL

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313808%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313808%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313808%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313808%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313808%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

332-339

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313808%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

cites work

Immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Paracrine cytokine adjuvants in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

IL-12: initiation cytokine for cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Combination gene therapy for liver metastasis of colon carcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Conditionally replicating herpes vectors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Expression of a functional foreign gene in adult mammalian brain following in Vivo transfer via a herpes simplex virus type 1 defective viral vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Determination of the Sequence Alteration in the DNA of the Herpes Simplex Virus Type 1 Temperature-sensitive Mutant ts K

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Abnormal forms of the herpes simplex virus immediate early polypeptide Vmw175 induce the cellular stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Characterization of anti-mouse IL-12 monoclonal antibodies and measurement of mouse IL-12 by ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

Mechanisms of action and toxicity of immunotherapy with cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

inferred from DOI database lookup

7 January 2021

based on heuristic

Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301392

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3301392

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313808%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 November 2019

1041491643

0 references

1 reference